0001209191-22-037512.txt : 20220616
0001209191-22-037512.hdr.sgml : 20220616
20220616170757
ACCESSION NUMBER: 0001209191-22-037512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lundberg Sven Ante
CENTRAL INDEX KEY: 0001682126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39979
FILM NUMBER: 221021407
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vor Biopharma Inc.
CENTRAL INDEX KEY: 0001817229
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 101
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-655-6580
MAIL ADDRESS:
STREET 1: 100 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 101
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-14
0
0001817229
Vor Biopharma Inc.
VOR
0001682126
Lundberg Sven Ante
C/O VOR BIOPHARMA INC.
100 CAMBRIDGEPARK DRIVE, SUITE 101
CAMBRIDGE
MA
02140
1
0
0
0
Stock Option (right to buy)
4.26
2022-06-14
4
A
0
16911
0.00
A
2032-06-13
Common Stock
16911
16911
D
This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
/s/ Rich Segal, Attorney-in-Fact
2022-06-16